Corpus ID: 217242512

Belimumab Treatment for Adults with Systemic Lupus Erythematosus: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines

@inproceedings{Chao2018BelimumabTF,
  title={Belimumab Treatment for Adults with Systemic Lupus Erythematosus: A Review of Clinical Effectiveness, Cost-Effectiveness, and Guidelines},
  author={Y. Chao and L. Adcock},
  year={2018}
}
Cutaneous Manifestations of “Lupus”: Systemic Lupus Erythematosus and Beyond
Passive Monoclonal and Polyclonal Antibody Therapies

References

SHOWING 1-10 OF 33 REFERENCES
Systematic review, and meta-analysis of steroidsparing effect, of biologic agents in randomized, placebo-controlled phase 3 trials for systemic lupus erythematosus
  • Semin Arthritis Rheum
  • 2018
Belimumab: A BLyS-Specific Inhibitor for Systemic Lupus Erythematosus
Efficacy and safety of subcutaneous belimumab in anti-dsDNA-positive, hypocomplementemic patients with systemic lupus erythematosus
  • Arthritis rheumatol
  • 2018
Efficacy and safety of subcutaneous belimumab in systemic lupus erythematosus: a fifty-two-week randomized, double-blind, placebo-controlled study. Arthritis rheumatol [Internet
  • 2017
Disease Control and Safety of Belimumab Plus Standard Therapy Over 7 Years in Patients with Systemic Lupus Erythematosus
...
1
2
3
4
...